High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: A randomised, placebo-controlled trial

by on 4 d'abril de 2022 with No hi ha comentaris
  • Alemany, A., Millat-Martinez, P., Corbacho-Monné, M., Malchair, P., Ouchi, D., Ruiz-Comellas, A., Vidal-Alaball, J., Blanco, J., Clotet, B., Mitjà, O., . . . CONV-ERT Group. (2022). High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: A randomised, placebo-controlled trial. The Lancet Respiratory Medicine, 10(3), 278-288. https://doi.org/10.1016/S2213-2600(21)00545-2

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *